Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Takashi Okumura

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103709729. Sources: OpenAlex.

Their work

Papers
17
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2016: 2 papers · 2017: 6 papers · 2018: 2 papers · 2019: 5 papers · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 17

  1. Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.12.273↗
  2. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2021.04.013↗
  3. An In Vitro Three-Dimensional Organotypic Model to Analyze Peripancreatic Fat Invasion in Pancreatic Cancer: A Culture System Based on Collagen Gel Embedding. Co-author DOI 10.1007/978-1-4939-8879-2_11↗
  4. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis. Co-author DOI 10.1007/s00432-019-02860-z↗
  5. Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion. Co-author DOI 10.1016/j.canlet.2018.12.005↗
  6. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination. Co-author DOI 10.1038/s41374-018-0171-z↗
  7. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. Co-author DOI 10.3892/ijo.2019.4812↗
  8. Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180. Co-author DOI 10.1016/j.canlet.2017.10.010↗
  9. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.03.031↗
  10. Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence. Co-author DOI 10.1007/s00268-017-4068-6↗
  11. Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells. Co-author DOI 10.1016/j.pan.2017.08.009↗
  12. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mi… Co-author DOI 10.1053/j.gastro.2017.01.010↗
  13. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancr… Co-author DOI 10.18632/oncotarget.15430↗
  14. Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination. Co-author DOI 10.3892/ijo.2016.3829↗
  15. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients. Co-author DOI 10.3892/ol.2017.6549↗
  16. Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility. Co-author DOI 10.1016/j.canlet.2016.01.016↗
  17. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model. Co-author DOI 10.1111/cas.13024↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenoki Ohuchida · 15 shared papers, 2016–2021 · strength 1.08
  2. Takao Ohtsuka · 14 shared papers, 2016–2021 · strength 0.92
  3. Yoshihiro Miyasaka · 13 shared papers, 2016–2021 · strength 0.83
  4. Masafumi Nakamura · 11 shared papers, 2016–2021 · strength 0.83
  5. Kohei Nakata · 11 shared papers, 2017–2021 · strength 0.72
  6. Kazuhiro Koikawa · 10 shared papers, 2017–2021 · strength 0.65
  7. Sho Endo · 9 shared papers, 2017–2019 · strength 0.54
  8. Toshiya Abe · 9 shared papers, 2017–2019 · strength 0.54
  9. Hiromichi Nakayama · 8 shared papers, 2017–2019 · strength 0.51
  10. Shin Takesue · 8 shared papers, 2017–2019 · strength 0.51
  11. Chika Iwamoto · 7 shared papers, 2017–2021 · strength 0.49
  12. Yohei Ando · 6 shared papers, 2017–2021 · strength 0.43
  13. Yoshinao Oda · 6 shared papers, 2016–2019 · strength 0.37
  14. Makoto Hashizume · 6 shared papers, 2017–2019 · strength 0.36
  15. Shin Kibe · 5 shared papers, 2017–2019 · strength 0.33
  16. Biao Zheng · 5 shared papers, 2016–2019 · strength 0.32
  17. Masafumi Sada · 5 shared papers, 2016–2018 · strength 0.28
  18. Koji Shindo · 3 shared papers, 2019–2021 · strength 0.26
  19. Masafumi Nakamura · 4 shared papers, 2017–2019 · strength 0.25
  20. Akiko Sagara · 3 shared papers, 2017–2021 · strength 0.23
  21. Kohei Horioka · 4 shared papers, 2016–2018 · strength 0.22
  22. Anirban Maitra · 2 shared papers, 2019–2022 · strength 0.22
  23. Bidyut Ghosh · 2 shared papers, 2019–2022 · strength 0.22
  24. Zilong Yan · 2 shared papers, 2017–2019 · strength 0.16
  25. Lotfi Abou‐Elkacem · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.